220 related articles for article (PubMed ID: 16444382)
1. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.
Alvarez RF; Mattos AA; Corrêa EB; Cotrim HP; Nascimento TV
Arq Gastroenterol; 2005; 42(4):256-62. PubMed ID: 16444382
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial.
Singh N; Gayowski T; Yu VL; Wagener MM
Ann Intern Med; 1995 Apr; 122(8):595-8. PubMed ID: 7887554
[TBL] [Abstract][Full Text] [Related]
3. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats.
Guarner C; Runyon BA; Heck M; Young S; Sheikh MY
Dig Dis Sci; 1999 Oct; 44(10):1957-62. PubMed ID: 10548343
[TBL] [Abstract][Full Text] [Related]
5. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
Sandhu BS; Gupta R; Sharma J; Singh J; Murthy NS; Sarin SK
J Gastroenterol Hepatol; 2005 Apr; 20(4):599-605. PubMed ID: 15836710
[TBL] [Abstract][Full Text] [Related]
6. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
[TBL] [Abstract][Full Text] [Related]
7. [Spontaneous bacterial peritonitis due to Gemella morbillorum in a patient under chronic treatment with norfloxacin].
Velayos Jiménez B; Fernández Salazar L; Aller Fuente R; del Olmo Martínez L; de la Calle Valverde F; Arranz Santos T; González Hernández JM
Gastroenterol Hepatol; 2008 Mar; 31(3):129. PubMed ID: 18341845
[No Abstract] [Full Text] [Related]
8. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
Lontos S; Gow PJ; Vaughan RB; Angus PW
J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
[TBL] [Abstract][Full Text] [Related]
9. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Fernández J; Navasa M; Gómez J; Colmenero J; Vila J; Arroyo V; Rodés J
Hepatology; 2002 Jan; 35(1):140-8. PubMed ID: 11786970
[TBL] [Abstract][Full Text] [Related]
10. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
Itha S; Sharma A; Bhatt G
J Gastroenterol Hepatol; 2006 Oct; 21(10):1634. PubMed ID: 16928235
[No Abstract] [Full Text] [Related]
11. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
[TBL] [Abstract][Full Text] [Related]
12. [Primary prophylaxis of spontaneous bacterial peritonitis].
Soriano G; Guarner C
Gastroenterol Hepatol; 1997; 20(6):312-4. PubMed ID: 9296848
[No Abstract] [Full Text] [Related]
13. [Bacterial infections in liver cirrhosis].
Papp M; Farkas A; Udvardy M; Tornai I
Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in liver cirrhosis: systematic review.
Pimentel R; Gregório C; Figueiredo P
Acta Gastroenterol Belg; 2021; 84(2):333-342. PubMed ID: 34217185
[TBL] [Abstract][Full Text] [Related]
15. Norfloxacin, ciprofloxacin, trimethoprim-sulfamethoxazole, and rifaximin for the prevention of spontaneous bacterial peritonitis: a network meta-analysis.
Wang W; Yang J; Liu C; Song P; Wang W; Xu H; Xia X
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):905-910. PubMed ID: 31107737
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim--sulfamethoxazole prophylaxis of spontaneous bacterial peritonitis.
Nishioka SD
Ann Intern Med; 1995 Nov; 123(10):810. PubMed ID: 7574208
[No Abstract] [Full Text] [Related]
17. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.
Fernández J; Navasa M; Planas R; Montoliu S; Monfort D; Soriano G; Vila C; Pardo A; Quintero E; Vargas V; Such J; Ginès P; Arroyo V
Gastroenterology; 2007 Sep; 133(3):818-24. PubMed ID: 17854593
[TBL] [Abstract][Full Text] [Related]
18. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.
Francés R; Zapater P; González-Navajas JM; Muñoz C; Caño R; Moreu R; Pascual S; Bellot P; Pérez-Mateo M; Such J
Hepatology; 2008 Mar; 47(3):978-85. PubMed ID: 18306221
[TBL] [Abstract][Full Text] [Related]
19. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
20. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
